These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
435 related items for PubMed ID: 27085554
1. Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up. Alderman MA, Daignault S, Wolf JS, Palapattu GS, Weizer AZ, Hafez KS, Kunju LP, Wu AJ. Hum Pathol; 2016 Sep; 55():1-10. PubMed ID: 27085554 [Abstract] [Full Text] [Related]
2. Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up. Alderman MA, Daignault S, Wolf JS Jr, Palapattu GS, Weizer AZ, Hafez KS, Kunju LP, Wu AJ. Hum Pathol.September 2016;55:1-10. Kryvenko ON. Urol Oncol; 2017 Jun; 35(6):452-453. PubMed ID: 28416106 [Abstract] [Full Text] [Related]
3. Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists. Williamson SR, Gadde R, Trpkov K, Hirsch MS, Srigley JR, Reuter VE, Cheng L, Kunju LP, Barod R, Rogers CG, Delahunt B, Hes O, Eble JN, Zhou M, McKenney JK, Martignoni G, Fleming S, Grignon DJ, Moch H, Gupta NS. Hum Pathol; 2017 May; 63():149-156. PubMed ID: 28315424 [Abstract] [Full Text] [Related]
4. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma. An J, Park CK, Kim M, Joo JW, Cho NH. Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058 [Abstract] [Full Text] [Related]
6. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling. Liu YJ, Ussakli C, Antic T, Liu Y, Wu Y, True L, Tretiakova MS. Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684 [Abstract] [Full Text] [Related]
7. Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics. Kravtsov O, Gupta S, Cheville JC, Sukov WR, Rowsey R, Herrera-Hernandez LP, Lohse CM, Knudson R, Leibovich BC, Jimenez RE. Hum Pathol; 2021 Aug; 114():9-18. PubMed ID: 33961838 [Abstract] [Full Text] [Related]
8. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics. Carvalho JC, Wasco MJ, Kunju LP, Thomas DG, Shah RB. Histopathology; 2011 Jan; 58(2):169-79. PubMed ID: 21323945 [Abstract] [Full Text] [Related]
9. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma. Kuroda N, Kanomata N, Yamaguchi T, Imamura Y, Ohe C, Sakaida N, Hes O, Michal M, Shuin T, Lee GH. Med Mol Morphol; 2011 Jun; 44(2):111-5. PubMed ID: 21717314 [Abstract] [Full Text] [Related]
13. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ. Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570 [Abstract] [Full Text] [Related]
14. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies. Conner JR, Hirsch MS, Jo VY. Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652 [Abstract] [Full Text] [Related]
15. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma. Memeo L, Jhang J, Assaad AM, McKiernan JM, Murty VV, Hibshoosh H, Tong GX, Mansukhani MM. Am J Clin Pathol; 2007 Feb; 127(2):225-9. PubMed ID: 17210525 [Abstract] [Full Text] [Related]
16. "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases. He H, Trpkov K, Martinek P, Isikci OT, Maggi-Galuzzi C, Alaghehbandan R, Gill AJ, Tretiakova M, Lopez JI, Williamson SR, Montiel DP, Sperga M, Comperat E, Brimo F, Yilmaz A, Pivovarcikova K, Michalova K, Slouka D, Prochazkova K, Hora M, Bonert M, Michal M, Hes O. Virchows Arch; 2018 Dec; 473(6):725-738. PubMed ID: 30232607 [Abstract] [Full Text] [Related]
17. p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma. McHugh JB, Hoschar AP, Dvorakova M, Parwani AV, Barnes EL, Seethala RR. Head Neck Pathol; 2007 Dec; 1(2):123-31. PubMed ID: 20614263 [Abstract] [Full Text] [Related]
18. Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma. Krüger S, Sotlar K, Kausch I, Horny HP. Oncology; 2005 Dec; 68(2-3):269-75. PubMed ID: 16015044 [Abstract] [Full Text] [Related]
19. Chromophobe renal cell carcinoma: a morphologic and immunohistochemical study of 45 cases. Din NU, Fatima S, Ahmad Z. Ann Diagn Pathol; 2013 Dec; 17(6):508-13. PubMed ID: 24095630 [Abstract] [Full Text] [Related]
20. Contemporary Characterization and Recategorization of Adult Unclassified Renal Cell Carcinoma. Kwon R, Argani P, Epstein JI, Lombardo KA, Wang X, Pierorazio PM, Mehra R, Matoso A. Am J Surg Pathol; 2021 Apr 01; 45(4):450-462. PubMed ID: 33239504 [Abstract] [Full Text] [Related] Page: [Next] [New Search]